Free cookie consent management tool by TermsFeed Policy Generator

Critical Reports Mount On Hepatitis C Pill Costs

17 May 20150

Gilead Sciences’ Sovaldi for Hepatitis C. (Photo credit: Bob Ecker/MCT/Newscom)

“We have millions of people who need treatment for hepatitis C and payers obviously don’t have the budget to cover this tremendous expense,” Jagpreet Chhatwal, the study’s lead author and an assistant professor of health services research at the The University of Texas M.D. Anderson Cancer Center said.

Read full story here.

Leave a Reply

Your email address will not be published. Required fields are marked *

©2024 Value Analytics Labs. All rights reserved | Terms of Service | Privacy Policy | Design by 9piksel